Composition for reducing blood pressure, blood sugar and blood fat

Abstract

The invention discloses a composition for reducing blood pressure, blood sugar and blood fat, and belongs to the technical field of food processing. The moringa oleifera health-care food is prepared from moringa oleifera leaf powder, mulberry leaf powder, wall-broken ganoderma lucidum spore powder, passion fruit powder, prune powder, sea buckthorn powder, roxburgh rose powder, acerola cherry powder, angelica keiskei powder, corn stigma extract, perfume lemon powder, cyclocarya paliurus extract, radix puerariae extract, globe artichoke extract, lecithin, enzymes, OMEGA-3, arabinose and fructo-oligosaccharide. The plant composition which is sour with sweetness and good in taste is prepared by compounding and seasoning all edible raw materials such as glucosyl stevioside / hesperidin, the plant composition has good effects of reducing blood pressure, blood sugar and blood fat, and the adopted raw materials are healthy, non-toxic, easy to obtain, non-toxic to human bodies, especially livers, suitable for popular use and good in application prospect.

Description

Technical Field

[0001] The invention relates to the technical field of food processing, and in particular to a composition for lowering blood pressure, blood sugar and blood lipid. Background Art

[0002] The so-called "three highs" refer to high blood sugar, high blood pressure, and high blood lipids, which are chronic diseases that many modern people are prone to. These three often appear together or one after another.

[0003] Hyperglycemia refers to the glucose content in the blood being higher than normal. The fasting blood sugar value of a normal person is 3.9-6.0mmol / L, and the blood sugar 2 hours after a meal is <7.7mmol / L. If the fasting blood sugar is ≥7.0mmol / L and the blood sugar 2 hours after a meal is ≥11.1mmol / L, it is diagnosed as diabetes. Hyperlipidemia refers to high blood lipid levels. The diagnostic criteria for hyperlipidemia are total cholesterol ≥6.2mmol / L, triglycerides ≥2.3mmol / L, and low-density lipoprotein cholesterol ≥4.1mmol / L. Among them, simple cholesterol increase is defined as hypercholesterolemia, simple triglyceride increase is defined as hypertriglyceridemia, and both cholesterol and triglyceride increase are defined as mixed hyperlipidemia. When the systolic blood pressure (high pressure) is ≥140mmHg and the diastolic blood pressure (low pressure) is ≥90mmHg, if one of these two values ​​is too high, it is hypertension. The blood pressure values ​​measured at three different times must be greater than 140 / or 90mmHg.

[0004] The three highs are "rich diseases" derived from modern society. They may exist alone or be related to each other. For example, diabetics are prone to high blood pressure or hyperlipidemia at the same time. Hyperlipidemia is the main factor in the formation and development of arteriosclerosis. The poor elasticity of blood vessels in arteriosclerosis patients exacerbates the increase in blood pressure. Therefore, if any of these three diseases occurs, it is easy to form the "three highs" in the later stage.

[0005] With the improvement of living standards and the change of the pace of life, the "three highs" (i.e., high blood pressure, high blood sugar and high blood lipids), known as "rich diseases", have become common diseases affecting the health of middle-aged and elderly people over 50 years old. Every year, 15 million people die from cardiovascular and cerebrovascular diseases, ranking first among all causes of death. Cardiovascular and cerebrovascular diseases have become the "number one killer" with the highest cause of death in humans, and are also the "silent evil spirit" of people's health! Cardiovascular and cerebrovascular diseases have the characteristics of high incidence, high disability rate, high mortality rate, high recurrence rate, and many complications, forming "four highs and one more". High blood lipids can cause vascular embolism; high blood pressure can cause cerebral hemorrhage and cerebral vascular rupture; high blood sugar can cause diabetes. Therefore, the first line of defense against cardiovascular disease is to reduce the "three highs" and control the "three highs". In addition, the "three highs" can also cause other metabolic syndromes, such as overweight, obesity, hyperuricemia, ventilation, fatty liver, polycystic ovary syndrome, and acanthosis nigricans.

[0006] Currently, the treatment for hypertension, hyperlipidemia and diabetes is mainly based on Western medicine, such as Olmesartan, Atorvastatin and Metformin. Long-term use of these medicines will be toxic to the liver and will not substantially improve the lesion organs that cause the three highs. Summary of the invention

[0007] [Technical issues]

[0008] The technical problem to be solved by the present invention is that long-term use of Western medicine for the treatment of hypertension, hyperlipidemia and diabetes will be toxic to the liver, and has no substantial therapeutic or improvement effect on the lesion organs causing the three highs.

[0009] [Technical solution]

[0010] In order to solve the above problems, the present invention provides a composition for lowering blood pressure, blood sugar and blood lipids, which is compounded with Moringa leaf powder and edible phytochemicals with effective ingredients to enhance the effect of lowering the three highs, and has the effects of comprehensive nutrient supplementation, anti-oxidation, anti-aging, and cancer prevention and anti-cancer.

[0011] The present invention provides a composition, which comprises the following components by weight: 10-15 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall ganoderma lucidum spore powder, 1-2.5 parts of kudzu root extract, 1-5 parts of roxburghii fruit powder, 1-2.5 parts of seabuckthorn powder, 1-2.5 parts of corn silk extract, 1-2.5 parts of Cyclocarya paliurus extract, 1-2.5 parts of prune fruit powder, 1.5-2.5 parts of perfume lemon fruit powder, 2.5 parts of oligofructose, 2-3 parts of arabinose, and 1-2.5 parts of egg white. 0-2 parts of lecithin, 0-2.5 parts of passion fruit powder, 0-2.5 parts of artichoke extract, 0-1.5 parts of hawthorn powder, 0-0.05 parts of glucosyl stevioside, 0-10 parts of linseed oil microcapsule powder, 0-1 part of acai berry powder, 0-1 part of acerola cherry powder, 0-1 part of tomorrow leaf powder, 0-1 part of black ginger powder, 0-1 part of sweet orange powder, 0-1 part of noni enzyme powder, 0-11 parts of Omega 3 fish oil powder, and 0-0.03 parts of hesperidin.

[0012] As a preferred embodiment of the present invention, the composition comprises the following components by weight: 10 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 2.5 parts of Pueraria extract, 5 parts of Rosa roxburghii fruit powder, 2.5 parts of Seabuckthorn powder, 2.5 parts of Corn Silk extract, 2.5 parts of Cyclocarya paliurus extract, 2.5 parts of Prunus citrinum fruit powder, 2.5 parts of Lemongrass fruit powder, 2.5 parts of Fructooligosaccharides, 2 parts of Arabinose, 2 parts of Lecithin, 2.5 parts of Passion Fruit Powder, 2.5 parts of Artichoke Extract, 1.5 parts of Hawthorn Powder, 0.05 parts of Glucose Stevioside, and 10 parts of Linseed Oil Microcapsule Powder.

[0013] As a preferred embodiment of the present invention, the composition comprises the following components by weight: 11-15 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 1 part of Pueraria root extract, 1 part of Rosa roxburghii fruit powder, 1 part of Hippophae rhamnoides powder, 1 part of Corn silk extract, 1 part of Cyclocarya paliurus extract, 1 part of Prunus citriodora fruit powder, 1.5 parts of Lemongrass fruit powder, 2.5 parts of oligofructose, 3 parts of arabinose, 1 part of Acai berry powder, 1 part of Acerola cherry powder, 1 part of Angelica keiskei powder, 1 part of black ginger powder, 1 part of sweet orange powder, 1 part of Noni fruit enzyme powder, 11 parts of Omega 3 fish oil powder, and 0.03 parts of hesperidin.

[0014] As a preferred embodiment of the present invention, the composition is a food, a medicine, a health product, or a special medical formula composition.

[0015] The present invention provides a method for preparing the above-mentioned composition, comprising the following steps:

[0016] According to the weight fraction ratio, take 10-15 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 1-2.5 parts of Pueraria extract, 1-5 parts of Rosa roxburghii fruit powder, 1-2.5 parts of Seabuckthorn powder, 1-2.5 parts of Corn silk extract, 1-2.5 parts of Cyclocarya paliurus extract, 1-2.5 parts of Prunus citrinum fruit powder, 1.5-2.5 parts of Lemon fruit powder, 2.5 parts of Fructooligosaccharides, 2-3 parts of Arabinose, 0-2 parts of Lecithin, 0-2.5 parts of Passion fruit powder, 0-2.5 parts of Artichoke extract, 0-1.5 parts of Hawthorn powder, and 0-2.5 parts of Glucose. 0-0.05 part of stevioside, 0-10 parts of linseed oil microcapsule powder, 0-1 part of acai berry powder, 0-1 part of acerola cherry powder, 0-1 part of ashitaba leaf powder, 0-1 part of black ginger powder, 0-1 part of sweet orange powder, 0-1 part of noni fruit enzyme powder, 0-11 parts of Omega 3 fish oil powder and 0-0.03 part of hesperidin are mixed evenly, konjac flour aqueous solution or linseed gum aqueous solution is added, the mixture is stirred into a uniform mass, freeze-dried to a water content of 5-6%, tableted and bagged to obtain a composition for lowering blood pressure, blood sugar and blood lipid.

[0017] As a preferred embodiment of the present invention, the mass concentration of the konjac flour aqueous solution or the flaxseed gum aqueous solution is 0.5-5%.

[0018] As a preferred embodiment of the present invention, the freeze-drying parameters are: pre-freezing at -40°C to -25 for 1 to 2 hours, freeze-drying cold trap temperature of -35°C, vacuum drying, vacuum degree 50 to 70Pa, and then two stages of analytical drying at -25°C and -5°C and two stages of sublimation drying at 15°C and 40°C.

[0019] As a preferred embodiment of the present invention, the addition amount of the konjac flour aqueous solution or the flaxseed gum aqueous solution is 0.5-5% of the mass of the above raw materials.

[0020] The present invention also provides the use of the above-mentioned composition in preparing medicines for treating hypertension, hyperglycemia and hyperlipidemia.

[0021] The present invention also provides the use of the above-mentioned composition in the preparation of health products that help maintain healthy blood lipid levels, help maintain healthy blood sugar levels, and help maintain healthy blood pressure levels.

[0022] [Beneficial Effects]

[0023] (1) The present invention uses all edible raw materials such as moringa leaf powder, mulberry leaf powder, broken wall ganoderma lucidum spore powder, passion fruit powder, prune fruit powder, sea buckthorn powder, roxburghii powder, acerola powder, akebia powder, corn silk extract, citrus fruit powder, cyclocarya paliurus extract, kudzu root extract, artichoke extract, lecithin, enzyme, Omega 3 fish oil powder, arabinose, oligofructose, glucosyl stevioside / hesperidin, etc. to compound seasoning to prepare a composition with good sour and sweet taste.

[0024] (2) The present invention contains many kinds of precious edible plants, and the raw materials contain tens of thousands of phytochemical components. Among them, the functional phytochemical ingredients have good effects on human target organs, repairing vascular lining cells, increasing vascular elasticity, purifying blood vessels, promoting vascular waste discharge, promoting liver detoxification and repair, and pancreatic islet repair. It has good effects on metabolic syndrome, fatty liver, and visceral fat reduction, and can fundamentally alleviate the causes of diseases, reshape the human body and get rid of Western medicine, greatly improving the health status and physical fitness of the whole people.

[0025] (3) The present invention compounds Moringa leaf powder with edible phytochemicals with effective ingredients to enhance the effect of lowering the three highs, and has the effects of comprehensive nutrient supplementation, anti-oxidation, anti-aging, and cancer prevention and anti-cancer. It is a necessity for daily health care for middle-aged and elderly people.

[0026] (4) The raw materials used in the present invention are healthy, non-toxic, easily available, non-toxic to the human body, especially the liver, suitable for mass use, and have good application prospects. DETAILED DESCRIPTION

[0027] Sources of raw materials used in the examples:

[0028] Moringa leaf powder: selenium-enriched Moringa leaf powder, selenium content 45μg / g, crushed into 500 mesh powder; mulberry leaf powder: crushed into 500 mesh powder; broken wall Ganoderma lucidum spore powder: Yuexi County Ganoderma lucidum Biotechnology Co., Ltd.; Pueraria extract: Zhongpeptide Biotechnology (Shanxi) Co., Ltd.; Rosa roxburghii fruit powder: Xi'an Four Seasons Biotechnology Co., Ltd.; Seabuckthorn powder: Xi'an Yihui Biotechnology Co., Ltd.; Corn silk extract: Shanxi Haoying Biotechnology Co., Ltd.; Cyclocarya paliurus extract: Shaanxi Ruilin Panier Biotechnology Co., Ltd.; Prune fruit powder: Xi'an Yihui Biotechnology Co., Ltd.; Perfume lemon fruit powder: Xi'an Saiyang Biotechnology Co., Ltd.; Fructooligosaccharides: Xi'an Huageng Biotechnology Co., Ltd., fructooligosaccharides 99%; Arabinose: Jinan Shengquan Tanghetang Biotechnology Co., Ltd., L-arabinose; Lecithin: Shanxi Yirun Biotechnology Co., Ltd.; Passion fruit powder: Hainan Nanpai Industrial Co., Ltd.; Artichoke extract: Shanxi Jinheng Chemical Co., Ltd.; Hawthorn powder :Shaanxi Yuanbeibei Biotechnology Co., Ltd.; Glucosyl stevioside: Qufu Shengren Pharmaceutical Co., Ltd.; Flaxseed oil microcapsule powder: Xi'an Virgin Biotechnology Co., Ltd., flaxseed oil microcapsule OMEGA-350% linolenic acid; Acai berry powder: Shaanxi Saien Biotechnology Co., Ltd.; Acerola powder: Hainan Nanpai Industrial Co., Ltd.; Tomorrow leaf powder: Shandong Tongyuan Gonghe Biotechnology Co., Ltd.; Black ginger powder: Xi'an Qingchun Kangmei Biotechnology Co., Ltd.; Sweet orange powder: Tianjin Zhenru Food Industry Co., Ltd.; Noni fruit enzyme powder: Shanxi Zhongnuo Biotechnology Co., Ltd.; Omega3 fish oil powder: Guoweixian (Xi'an) Food Ingredients Co., Ltd., Omega3 fish oil powder (DHA+EPA≥15%); Hesperidin: Shandong Benyue Biotechnology Co., Ltd.; Konjac flour: Wuhan Qingjiang Konjac Products Co., Ltd., Konjac flour MW-90; Flaxseed gum: Xinjiang Lishide Biotechnology Co., Ltd., Flaxseed gum R400.

[0029] In the following examples, 1 part by weight means 100 g.

[0030] Example 1

[0031] The present embodiment provides a composition for lowering blood pressure, blood sugar and blood lipids, comprising, by weight: 10 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 2.5 parts of Pueraria root extract, 5 parts of Rosa roxburghii fruit powder, 2.5 parts of Hippophae rhamnoides powder, 2 parts of lecithin, 2.5 parts of Corn silk extract, 2.5 parts of Cyclocarya paliurus extract, 2.5 parts of Prunus citriodora fruit powder, 2.5 parts of passion fruit powder, 2.5 parts of Lemon citrus fruit powder, 2.5 parts of Artichoke extract, 1.5 parts of Hawthorn powder, 2.5 parts of Fructooligosaccharides, 2 parts of Arabinose, 0.05 parts of Glucose Sylvia stevioside, and 10 parts of linseed oil microcapsule powder.

[0032] The specific steps of preparing the composition are as follows:

[0033] Weigh 10 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 2.5 parts of Pueraria extract, 5 parts of Rosa roxburghii fruit powder, 2.5 parts of Seabuckthorn powder, 2 parts of lecithin, 2.5 parts of Corn silk extract, 2.5 parts of Cyclocarya paliurus extract, 2.5 parts of Prunus citrifolia fruit powder, 2.5 parts of Passion fruit powder, 2.5 parts of Lemon fruit powder, 2.5 parts of Artichoke extract, 1.5 parts of Hawthorn powder, 2.5 parts of Fructooligosaccharides, 2 parts of Arabinose, 0.05 parts of Glucose styrene, and 10 parts of linseed oil microcapsule powder according to weight fraction ratio, mix the above raw materials evenly, add linseed gum aqueous solution, the mass concentration of the linseed gum aqueous solution is 1%, and the amount of the linseed gum aqueous solution added is 1% of the mass of the above raw materials. The mixture is stirred into a uniform mass, and dried in a vacuum freeze dryer for 2 days (pre-freeze at -40°C for 2 hours, freeze-drying cold trap temperature of -35°C, vacuum drying, vacuum degree 50-70Pa, and then subjected to two stages of analytical drying at -25°C and -5°C and two stages of sublimation drying at 15°C and 40°C) until the water content is 5-6%, and then pressed into 2.5g oval sheet samples using a rotary tablet press, and sealed in bags to obtain a composition for lowering blood pressure, blood sugar and blood lipids.

[0034] Example 2

[0035] The present embodiment provides a composition for lowering blood pressure, blood sugar and blood lipids, comprising, by weight: 11 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 1 part of acai berry powder, 1 part of acerola cherry powder, 1 part of prune fruit powder, 1 part of roxburghii fruit powder, 1 part of kudzu root extract, 1 part of Cyclocarya paliurus extract, 1 part of seabuckthorn powder, 1 part of Angelica keiskei powder, 1 part of corn silk extract, 1 part of black ginger powder, 1 part of sweet orange powder, 1 part of noni fruit enzyme powder, 1.5 parts of scented lemon fruit powder, 11 parts of Omega 3 fish oil powder, 3 parts of arabinose, 2.5 parts of oligofructose, and 0.03 parts of hesperidin.

[0036] The specific steps of preparing the composition are as follows:

[0037] Weigh 11 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 1 part of acai berry powder, 1 part of acerola powder, 1 part of prune fruit powder, 1 part of roxburghii fruit powder, 1 part of kudzu root extract, 1 part of Cyclocarya paliurus extract, 1 part of seabuckthorn powder, 1 part of tomorrow leaf powder, 1 part of corn silk extract, 1 part of black ginger powder, 1 part of sweet orange powder, 1 part of noni fruit enzyme powder, 1.5 parts of perfume lemon fruit powder, Omega 11 parts of 3 fish oil powders, 3 parts of arabinose, 2.5 parts of oligofructose, and 0.03 part of hesperidin are mixed uniformly, and konjac flour aqueous solution is added, the mass concentration of the konjac flour aqueous solution is 1%, and the addition amount of the konjac flour aqueous solution is 1% of the mass of the above raw materials, and mixing is formed into a uniform agglomerate, and dried for 2 days in a vacuum freeze dryer (-40 ℃ prefreeze 2h, freeze-drying cold trap temperature-35 ℃, vacuum drying, vacuum degree 50-70Pa, then through-25 ℃, -5 ℃ two-stage analytical drying and 15 ℃, 40 ℃ two-stage sublimation drying), the sample water content is about 5-6%, and is pressed into 2.5g oval sheet sample with a rotary tablet press, and is bagged and sealed to obtain a composition for lowering blood pressure, blood sugar and blood lipid.

[0038] Example 3

[0039] The formula and preparation method of reference example 2 are different only in that: the Moringa leaf powder is 15 parts.

[0040] Comparative Example 1

[0041] The recipe and preparation method of reference example 2 are different only in that: Moringa leaf powder is omitted.

[0042] Comparative Example 2

[0043] The formula and preparation method of Reference Example 2 are the same, except that the Omega 3 fish oil powder is omitted.

[0044] Test Example 1

[0045] The compositions prepared in Examples 1 to 3 and Comparative Examples 1 to 2 were taken by 183 volunteers for one month. The 112 volunteers were aged between 45 and 65 years old, both male and female, and all had symptoms of high blood sugar, high blood lipids, and high blood pressure. They were taken twice a day, 2 tablets of 5 g each time on an empty stomach in the morning; and 2 tablets of 5 g each time before going to bed at night, taken with warm water. The improvements in blood sugar, blood lipids, and blood pressure were examined. The results are shown in Table 1.

[0046] The standard for effective blood sugar changes: blood sugar reduction rate ≥ 10%, blood sugar reduction rate = (fasting blood sugar value before taking - fasting blood sugar value after 1 month of taking) / fasting blood sugar value before taking; the standard for invalid blood sugar changes: blood sugar reduction rate < 10%.

[0047] The standard for valid blood pressure changes: systolic pressure ≤ 130, diastolic pressure ≤ 90; the standard for invalid blood pressure changes: systolic pressure > 130, or diastolic pressure > 90.

[0048] The standard for effective blood lipid changes: low-density lipoprotein cholesterol is lower than 3.1mmol / L; the standard for invalid blood lipid changes: low-density lipoprotein cholesterol is greater than 3.1mmol / L.

[0049] Table 1 Changes in blood pressure, blood lipids and blood sugar of volunteers

[0050]

[0051] As can be seen from Table 1, taking the composition prepared by the present invention has a good effect of lowering blood pressure, blood sugar and blood lipids. The subjects generally reacted that after taking it, dizziness and vertigo were significantly improved, and their spirits were good.

[0052] The embodiments provided above are not intended to limit the scope of the present invention, and the steps described are not intended to limit the execution order thereof. Those skilled in the art may make obvious improvements to the present invention in combination with existing common knowledge, which also fall within the scope of protection defined by the claims of the present invention.

Claims

1. A composition, characterized in that The following components are included by weight: 10-15 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 1-2.5 parts of Pueraria extract, 1-5 parts of Rosa roxburghii fruit powder, 1-2.5 parts of Seabuckthorn powder, 1-2.5 parts of Corn silk extract, 1-2.5 parts of Cyclocarya paliurus extract, 1-2.5 parts of Prunus citrifolia fruit powder, 1.5-2.5 parts of Lemon fruit powder, 2.5 parts of Fructooligosaccharides, 2-3 parts of Arabinose, 0-2 parts of Lecithin , 0-2.5 parts of passion fruit powder, 0-2.5 parts of artichoke extract, 0-1.5 parts of hawthorn powder, 0-0.05 parts of glucosyl stevioside, 0-10 parts of linseed oil microcapsule powder, 0-1 part of acai berry powder, 0-1 part of acerola cherry powder, 0-1 part of tomorrow leaf powder, 0-1 part of black ginger powder, 0-1 part of sweet orange powder, 0-1 part of noni fruit enzyme powder, 0-11 parts of Omega 3 fish oil powder, and 0-0.03 parts of hesperidin.

2. The composition according to claim 1, characterized in that The invention comprises the following components by weight: 10 parts of moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall ganoderma lucidum spore powder, 2.5 parts of kudzu root extract, 5 parts of roxburghii fruit powder, 2.5 parts of sea buckthorn powder, 2.5 parts of corn silk extract, 2.5 parts of cyclocarya paliurus extract, 2.5 parts of prune fruit powder, 2.5 parts of citrus aurantium fruit powder, 2.5 parts of oligofructose, 2 parts of arabinose, 2 parts of lecithin, 2.5 parts of passion fruit powder, 2.5 parts of artichoke extract, 1.5 parts of hawthorn powder, 0.05 parts of glucosyl stevioside and 10 parts of linseed oil microcapsule powder.

3. The composition according to claim 1, characterized in that The invention comprises the following components by weight: 11 to 15 parts of moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall ganoderma lucidum spore powder, 1 part of kudzu root extract, 1 part of roxburghii fruit powder, 1 part of sea buckthorn powder, 1 part of corn silk extract, 1 part of cyclocarya paliurus extract, 1 part of prune fruit powder, 1.5 parts of citrus fruit powder, 2.5 parts of oligofructose, 3 parts of arabinose, 1 part of acai berry powder, 1 part of acerola cherry powder, 1 part of tomorrow leaf powder, 1 part of black ginger powder, 1 part of sweet orange powder, 1 part of noni fruit enzyme powder, 11 parts of Omega 3 fish oil powder and 0.03 parts of hesperidin.

4. The composition according to claim 1, characterized in that The composition is a medicine, food, health product, or a special medical formula composition.

5. The method for preparing the composition according to claim 1, characterized in that: The steps include: According to the weight ratio, take 10-15 parts of Moringa leaf powder, 1 part of mulberry leaf powder, 1 part of broken wall Ganoderma lucidum spore powder, 1-2.5 parts of Pueraria extract, 1-5 parts of Rosa roxburghii fruit powder, 1-2.5 parts of Seabuckthorn powder, 1-2.5 parts of Corn silk extract, 1-2.5 parts of Cyclocarya paliurus extract, 1-2.5 parts of Prunus citrinum fruit powder, 1.5-2.5 parts of Lemon fruit powder, 2.5 parts of Fructooligosaccharides, 2-3 parts of Arabinose, 0-2 parts of Lecithin, 0-2.5 parts of Passion fruit powder, 0-2.5 parts of Artichoke extract, 0-1.5 parts of Hawthorn powder, 0-2.5 parts of Glucose-based sweetener. 0-0.05 parts of inulin glycoside, 0-10 parts of linseed oil microcapsule powder, 0-1 part of acai berry powder, 0-1 part of acerola cherry powder, 0-1 part of ashitaba leaf powder, 0-1 part of black ginger powder, 0-1 part of sweet orange powder, 0-1 part of noni fruit enzyme powder, 0-11 parts of Omega 3 fish oil powder and 0-0.03 parts of hesperidin are mixed evenly, konjac flour aqueous solution or linseed gum aqueous solution is added, the mixture is stirred into a uniform mass, freeze-dried to a water content of 5-6%, tableted and bagged to obtain a plant composition for lowering blood pressure, blood sugar and blood lipid.

6. The method for preparing the composition according to claim 5, characterized in that: The mass concentration of the konjac flour aqueous solution or the flaxseed gum aqueous solution is 0.5-5%.

7. The method for preparing the composition according to claim 5, characterized in that: The freeze-drying parameters are: pre-freezing at -40℃~-25 for 1~2 hours, freeze-drying cold trap temperature of -35℃, vacuum drying, vacuum degree 50~70Pa, and then two stages of analytical drying at -25℃ and -5℃ and two stages of sublimation drying at 15℃ and 40℃.

8. The method for preparing the composition according to claim 5, characterized in that: The added amount of the konjac flour aqueous solution or the flaxseed gum aqueous solution is 0.5-5% of the mass of the above raw materials.

9. The method for preparing the composition according to claim 5, characterized in that: The added amount of the konjac flour aqueous solution or the flaxseed gum aqueous solution is 1% of the mass of the above raw materials.

10. Use of the composition according to any one of claims 1 to 4 in the preparation of a health product that helps maintain healthy blood lipid levels, helps maintain healthy blood sugar levels, and helps maintain healthy blood pressure levels.

Images